The additional, higher-molecular-weight CXCL12–KRT19 complexes formed with recombinant proteins (Fig. 2D) may indicate that cancer cells have additional constraints on the TGM2-mediated cross-linking of these proteins. The gene discussed is TGM2; the disease is cancer.